Celebrex


Also found in: Thesaurus, Medical, Wikipedia.
Related to Celebrex: Tramadol
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Celebrex - a Cox-2 inhibitor (trade name Celebrex) that relieves pain and inflammation without harming the digestive tract
Cox-2 inhibitor - an anti-inflammatory drug that fights pain and blocks Cox-2 activity without impeding the activity of Cox-1; increases the risk of heart attacks; "Cox-2 inhibitors reduce the symptoms of arthritis without endangering the stomach and kidneys"
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
After FDA approval of Celebrex in December 1998 and then Vioxx in May 1999, insurance companies tried to limit prescriptions of both drugs.
Surely you have seen Marjorie Jackson in the Celebrex commercials running on practically every TV channel on the dial.
The strength of drugs such as Celebrex and Xalatan .
They also found that the new pharmaceutical COX-2 Is--namely Celebrex and Vioxx--may work even more dramatically.
This means that at the higher 15-mg dose, "you're getting into COX-1 inhibition as well," which is in contrast to Celebrex (celecoxib) and Vioxx (rofecoxib), which do not inhibit COX- 1 at therapeutic doses, he said.
WHEN SEARLE DECIDED IN JANUARY 1998 to launch Celebrex, a chronic pain reliever, the U.
Cuando en enero de 1998 Searle decidio lanzar Celebrex, un calmante para dolores cronicos, la empresa farmaceutica estadounidense tenia tres elementos para apoyar el producto: un farmaco revolucionario, acceso a publicidad directa al consumidor y una alianza estrategica de mercadeo con el coloso Pfizer.
to market a generic equivalent of Celebrex, even though the company is appealing a federal court's refusal to block the US Food & Drug Administration (FDA) from granting a competitor generic exclusivity for 180 days.
M2 PHARMA-May 1, 2014-Actavis sues FDA for delaying approval of generic Celebrex
M2 EQUITYBITES-May 1, 2014-Actavis sues FDA for delaying approval of generic Celebrex
will pay $450 million to settle a six-year lawsuit filed by Brigham Young University (BYU) over the development of the anti-inflammatory drug Celebrex, according to a regulatory filing Tuesday.
Washington, Dec 24 (ANI): People who take painkiller Celebrex and also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke might not be getting enough protection because the former drug keeps the aspirin from doing its job effectively, according to a new study.